期刊文献+

三联用药联合中药治疗幽门螺杆菌阳性胃溃疡患者的疗效研究 被引量:2

Efficacy of Triple Therapy Combined With Traditional Chinese Medicine in the Treatment of Helicobacter Pylori Positive Gastric Ulcer
下载PDF
导出
摘要 目的研究奥美拉唑、左氧氟沙星与阿奇霉素三联用药联合温胃汤治疗幽门螺杆菌阳性胃溃疡患者的疗效及复发情况。方法将本所诊治的64例幽门螺杆菌(HP)相关性胃溃疡患者随机均分为常规组与联合组,常规组给予奥美拉唑、左氧氟沙星、阿奇霉素三联用药治疗,联合组在常规组的基础上加用温胃汤进行治疗。结果联合组总有效率为96.88%,HP根除率为90.63%;常规组总有效率为75.00%,HP根除率为65.63%;联合组总有效率与HP根除率均高于常规组,P<0.05;联合组复发率为3.13%,常规组复发率为34.38%,联合组复发率低于常规组,P<0.01。结论三联用药联合中药治疗幽门螺杆菌阳性胃溃疡疗效确切,安全可靠。 Objective To study the efficacy and recurrence in patients with omeprazole,levofloxacin and azithromycin triple therapy combined with warm stomach Decoction in the treatment of Helicobacter pylori positive gastric ulcer. Methods The 64 patients with Helicobacter pylori(HP)-associated gastric ulcer were randomly divided into routine group and combined group,conventional group given omeprazole,levofloxacin,azithromycin triple drug therapy,combination group on the basis of conventional group was treated with warm stomach soup. Results The total effective rate of the combined group was 96.88%,and the eradication rate of HP was 90.63%. The total effective rate of the conventional group was 75.00%,and the HP eradication rate was 65.63%. The total effective rate and eradication rate of HP in the combined group were higher than those in the conventional group,P〈0.05. The recurrence rate was 3.13% in the combined group,and the recurrence rate was 34.38% in the conventional group. The recurrence rate of the combined group was lower than that of the conventional group,P〈0.01. Conclusion The triple therapy combined with traditional Chinese medicine in treatment of Helicobacter pylori positive gastric ulcer is accurate,safe and reliable.
作者 张凤明
出处 《中国卫生标准管理》 2016年第18期121-123,共3页 China Health Standard Management
关键词 幽门螺杆菌 胃溃疡 三联用药 中西结合 Helicobacter pylori Gastric ulcer Triple therapy Combination of Chinese and Western
  • 相关文献

二级参考文献62

  • 1宋慧东,舒建昌,杨绮红,张文茹,吕霞,罗国彪,聂丽芬.雷贝拉唑四联疗法根除幽门螺杆菌感染疗效观察[J].南方医科大学学报,2009,29(7):1501-1502. 被引量:4
  • 2胡伏莲.幽门螺杆菌感染的流行病学[J].中国医刊,2007,42(2):17-18. 被引量:146
  • 3Bjorkholm B, Befrits R, Jaup B, et al.Rapid PCR detection of Helicobacter pylori-associated virulence and resistance genes directly from gastric biopsy material[J].Journal of Clinical Microbiology, 1998, 36 ( 12 ) : 3689-3690. 被引量:1
  • 4Lemke L B, Ge Z, Whary M T, et al.Concurrent Helicobacter bilis infection in C57BL/6 mice attenuates proinflammatory H. pylori- induced gastric pathology[J].Infeetion and Immunity, 2009, 77 ( 5 ) : 2147-2158. 被引量:1
  • 5Manente L, Perna A, Buommino E, et al.The Hclicobacter pylori's protein VacA has direct effects on the regulation of cell eycle and apoptosis in gastric epithelia/cells[JI.Journal of Cellular/?hysiology, 2008, 214 ( 3 ) : 582-587. 被引量:1
  • 6Gatti L L, Fagundese Souza E K, Leite K R, et al.CagA, vacA alelles and babA2 genotypes of Helicobactcr pylori associated with gastric disease in Brazilian adult patients[J].Diagnostic Microbiology and Infectious Disease, 2005, 51 (4) : 231-235. 被引量:1
  • 7Thjodleifsson B, Arnsdottir H, Sigurjonsdottir R B, et al.Seroprevalence of Helicobacter pylori and cagA antibodias in Iceland, Estonia and Sweden[J].Scandinavian Journal of Infectious Diseases, 2007, 39 ( 8 ) : 683-689. 被引量:1
  • 8Abadi T B, Rafiei A, Ajami A, et al.Helicobacter pylori homB, but not cagA, is associated with gastric cancer in lran[J].Jouroal of Clinical Microbiology, 2011, 49 ( 9 ) : 3191-3197. 被引量:1
  • 9莫剑忠,姜石湖,肖树东.胃肿瘤[M]//姜绍基胃肠病学.第2版.上海:上海科学技术出版,2014:493-498. 被引量:1
  • 10Ford A C,Forman D,Hunt R H,et al.Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals:systematic review and meta-analysis of randomised controlled trials[J].British Medical Journal,2014,20(1):348:3174. 被引量:1

同被引文献12

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部